Marketdash

Four Expert Stock Picks From CNBC's Final Trades Segment

MarketDash Editorial Team
18 hours ago
Market strategists shared their top picks on CNBC, ranging from a healthcare REIT with a hefty dividend to a streaming giant posting impressive earnings.

When market pros share their final picks of the day on CNBC's "Halftime Report Final Trades," it's worth paying attention. Wednesday's lineup featured a healthcare REIT, a private equity powerhouse, a value ETF, and everyone's favorite music streaming platform.

Jenny Van Leeuwen Harrington, chief executive officer of Gilman Hill Asset Management, made the case for Sabra Health Care REIT, Inc. (SBRA). The appeal? A solid 6.3% dividend yield in a sector that won't be disrupted by artificial intelligence anytime soon. Plus, as Harrington pointed out, demographics are working in their favor—people are getting older, and they're going to need healthcare facilities.

The pick looks even better considering Wells Fargo analyst John Kilichowski maintained his Overweight rating on November 25 and bumped the price target from $20 to $21.

Kari Firestone, co-founder of Aureus Asset Management, went with Apollo Global Management, Inc. (APO) as her top choice. The alternative asset manager has been catching Wall Street's eye lately. Morgan Stanley analyst Michael Cyprys upgraded the stock from Equal-Weight to Overweight on November 20, raising his price target significantly from $151 to $180.

Liz Thomas, SoFi's head of investment strategy, took a different approach and selected the iShares Russell 1000 Value ETF (IWD) for investors looking to play the value rotation.

Meanwhile, Joseph M. Terranova, senior managing director for Virtus Investment Partners, said he's buying Spotify Technology S.A. (SPOT). The timing makes sense. Spotify absolutely crushed its third-quarter earnings on November 4, reporting earnings of $3.83 per share—more than double the analyst consensus estimate of $1.87. Revenue hit $4.99 billion (4.19 billion euros), up 7% year over year and beating projections of $4.92 billion.

Price Action:

Four Expert Stock Picks From CNBC's Final Trades Segment

MarketDash Editorial Team
18 hours ago
Market strategists shared their top picks on CNBC, ranging from a healthcare REIT with a hefty dividend to a streaming giant posting impressive earnings.

When market pros share their final picks of the day on CNBC's "Halftime Report Final Trades," it's worth paying attention. Wednesday's lineup featured a healthcare REIT, a private equity powerhouse, a value ETF, and everyone's favorite music streaming platform.

Jenny Van Leeuwen Harrington, chief executive officer of Gilman Hill Asset Management, made the case for Sabra Health Care REIT, Inc. (SBRA). The appeal? A solid 6.3% dividend yield in a sector that won't be disrupted by artificial intelligence anytime soon. Plus, as Harrington pointed out, demographics are working in their favor—people are getting older, and they're going to need healthcare facilities.

The pick looks even better considering Wells Fargo analyst John Kilichowski maintained his Overweight rating on November 25 and bumped the price target from $20 to $21.

Kari Firestone, co-founder of Aureus Asset Management, went with Apollo Global Management, Inc. (APO) as her top choice. The alternative asset manager has been catching Wall Street's eye lately. Morgan Stanley analyst Michael Cyprys upgraded the stock from Equal-Weight to Overweight on November 20, raising his price target significantly from $151 to $180.

Liz Thomas, SoFi's head of investment strategy, took a different approach and selected the iShares Russell 1000 Value ETF (IWD) for investors looking to play the value rotation.

Meanwhile, Joseph M. Terranova, senior managing director for Virtus Investment Partners, said he's buying Spotify Technology S.A. (SPOT). The timing makes sense. Spotify absolutely crushed its third-quarter earnings on November 4, reporting earnings of $3.83 per share—more than double the analyst consensus estimate of $1.87. Revenue hit $4.99 billion (4.19 billion euros), up 7% year over year and beating projections of $4.92 billion.

Price Action: